i think what a lot of people are trying to lean from a case here or a case there is very premature, because it's really a matter of seeing how it performs as irs. And that's just going to take more time than i think. The mutation alone, higlihts the fact that this is going in the direction of te sort of fluvacine model. We probably are going to need somewhat different vaccines on a regular basis if chronovirus is going to linger like this in the population. But we still do have a substantial amount of accian hesitancy in this country. I certainly am totally have heard o lat there's a lot of demand for booster
Bloomberg Markets Correspondent Kriti Gupta and Bloomberg Intelligence Chief Industry Economist Carl Riccadonna discuss U.S. job growth registering its smallest gain this year while the unemployment rate fell by more than forecast to 4.2%. The Muse CEO Kathryn Minshew shares her thoughts on what’s happening within the Millennial and Gen Z workforce. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Health Care Reporter Cynthia Koons share Cynthia's Businessweek Magazine story Whether or Not It’s a Game Changer, Omicron Is Covid’s Future. Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the emergence of the omicron variant in the U.S. Ben Armstrong, Founder of BitBoy Crypto, breaks down cryptocurrency investing and volatility.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.